This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Napolitano, D. R.
Right arrow Articles by Campos-Neto, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Napolitano, D. R.
Right arrow Articles by Campos-Neto, A.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, April 2008, p. 638-643, Vol. 15, No. 4
1071-412X/08/$08.00+0     doi:10.1128/CVI.00010-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Identification of Mycobacterium tuberculosis Ornithine Carboamyltransferase in Urine as a Possible Molecular Marker of Active Pulmonary Tuberculosis{triangledown}

Danielle R. Napolitano ,1,{dagger},{ddagger} Nira Pollock,2,{ddagger} Suely S. Kashino,1,{ddagger} Virmondes Rodrigues Jr.,3 and Antonio Campos-Neto1,4*

The Forsyth Institute, Boston, Massachusetts 02115,1 Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215,2 Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil,3 University of Massachusetts Medical School, Worcester, Massachusetts 016554

Received 9 January 2008/ Returned for modification 1 February 2008/ Accepted 13 February 2008

Although the antigen detection assay has the potential to discriminate active tuberculosis from latent infection, development of such a test for the accurate diagnosis of this serious disease has only recently become a matter of interest. Here we present evidence that a Mycobacterium tuberculosis protein (ornithine carboamyltransferase, coded for by MT_1694; Rv1656 [argF]) is an interesting candidate molecule for this test development. The protein was initially discovered by mass spectroscopy in urine of patients with pulmonary tuberculosis and shown by Western blot analysis to be present in M. tuberculosis crude cell extract as well as in the culture supernatant ("secreted" protein). In addition, a recombinant ornithine carboamyltransferase (rMT1694) produced in Escherichia coli was recognized by immunoglobulin G (IgG) antibodies from patients with active tuberculosis but not by IgG from uninfected healthy subjects. Moreover, rMT1694 was strongly recognized by peripheral blood mononuclear cells from both healthy tuberculin purified protein derivative (PPD)-positive individuals and patients with pulmonary tuberculosis. More importantly, a capture enzyme-linked immunosorbent assay formatted with rabbit IgG antibodies specific to rMT1694 was able to identify the presence of this antigen in urine samples from 6 of 16 patients with pulmonary tuberculosis and in none of 16 urine samples collected from healthy PPD+ controls. These results indicate that an improved antigen detection assay based on M. tuberculosis ornithine carboamyltransferase may represent an important new strategy for the development of a specific and accurate diagnostic test for tuberculosis.


* Corresponding author. Mailing address: The Forsyth Institute, 140 The Fenway, Boston, MA 02115. Phone: (617) 892-8393. Fax: (617) 262-4021. E-mail: acampos{at}forsyth.org

{triangledown} Published ahead of print on 27 February 2008.

{dagger} Present address: Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.

{ddagger} D.R.N., N.P., and S.S.K. contributed equally to this work.


Clinical and Vaccine Immunology, April 2008, p. 638-643, Vol. 15, No. 4
1071-412X/08/$08.00+0     doi:10.1128/CVI.00010-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.